Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
877.79
-31.53 (-3.47%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eli Lilly
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
99
100
Next >
Eli Lilly Has Likely Blockbuster Drug, Elevated To Stock Spotlight: Joins These Names Just Added To IBD's Top Screens
June 11, 2024
Eli Lilly hit another all-time high Tuesday. It's seeing gains in large part because it's a leader in drugs to treat obesity and diabetes
Via
Investor's Business Daily
Eli Lilly's Donanemab Gains Favorable FDA Advisory Verdict, Boosting Stock Potential, Says BofA Analyst
June 11, 2024
Eli Lilly's donanemab for Alzheimer's disease garners positive FDA committee verdict, prompting analyst's bullish outlook amid comparisons to Biogen's Leqembi.
Via
Benzinga
Exposures
Product Safety
10 Health Care Stocks With Whale Alerts In Today's Session
June 11, 2024
Via
Benzinga
Eli Lilly Drags Alzheimer's Stocks Prothena, Eisai Lower Despite FDA Win
June 11, 2024
An FDA panel unanimously backed Eli Lilly's Alzheimer's drug, but shares of Lilly and its rivals fell Tuesday.
Via
Investor's Business Daily
Exposures
Product Safety
Why Are Stocks Down Today?
June 11, 2024
Stocks are down today and investors seeking out the answers to why that's the case will want to stick around for our Tuesday coverage.
Via
InvestorPlace
Unpacking the Latest Options Trading Trends in Eli Lilly and Co
June 10, 2024
Via
Benzinga
Eli Lilly Stock Hits New 52-Week High as FDA Panel Recommends Alzheimer’s Drug
June 11, 2024
Eli Lilly stock is up on Tuesday as investors in LLY celebrate an FDA panel putting its support behind the company's Alzheimer's drug.
Via
InvestorPlace
Exposures
Product Safety
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
June 11, 2024
EQNX::TICKER_START (NASDAQ:TLSA),(NYSE:LLY),(OTCQX:RHHBY),(NASDAQ:BIIB),(NASDAQ:TGTX) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
Product Safety
Top 4 Health Care Stocks That May Keep You Up At Night This Month
June 11, 2024
Via
Benzinga
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
June 11, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Why Is Eli Lilly Stock Trading Higher Premarket Tuesday?
June 11, 2024
Shares of Eli Lilly surged as an FDA advisory committee endorsed donanemab, an Alzheimer's treatment shown to significantly impact early-stage patients. The drug's benefits outstripped risks, setting...
Via
Benzinga
Exposures
Product Safety
Eli Lilly Hits an All-Time High: Is the Soaring Pharma Stock Still a Buy?
June 11, 2024
The world's biggest healthcare company might become even larger.
Via
The Motley Fool
Structure Therapeutics Stock Could Rocket 87% Higher, According to 1 Wall Street Analyst. Is It Time to Buy?
June 11, 2024
Analysts who follow the start-up drugmaker think its stock has a chance to soar, but that doesn't mean it's right for you.
Via
The Motley Fool
Apple, Meta, Celsius, Eli Lilly, Tesla: Why These 5 Stocks Are On Investors' Radars Today
June 10, 2024
On Monday, major U.S. indices closed positively, with the Dow Jones Industrial Average rising by 0.2% to 38,868.04.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
7 Over-Hyped Stocks to Sell Before They Plunge: June Edition
June 10, 2024
Although these popular names may be hot now, soon the market could agree that they are over-estimated stocks to sell.
Via
InvestorPlace
Eli Lilly Rises Again, As FDA Panel Mulls Biogen-Rivaling Alzheimer's Drug
June 10, 2024
The FDA isn't bound by the committee's recommendation, but often follows it.
Via
Investor's Business Daily
Exposures
Product Safety
What's Happening With Eli Lilly Shares On Monday?
June 10, 2024
Eli Lilly reports detailed results from the SYNERGY-NASH phase 2 study. The trial, involving 190 patients with and without type 2 diabetes, showed tirzepatide met the primary endpoint, achieving MASH...
Via
Benzinga
Abbott Snags U.S. Clearance To Enter The Obesity Arena, Rivaling Dexcom
June 10, 2024
The FDA clearance for two new CGMs puts Abbott on track to rival Dexcom's new Stelo device.
Via
Investor's Business Daily
Exposures
Product Safety
7 Blue-Chip Stocks to Add to Your June Buy List
June 10, 2024
There are huge advantages to having blue-chip stocks in your portfolio, particularly when the stock market is on a roll. Consider these.
Via
InvestorPlace
The Company Behind Mounjaro and Zepbound Is Sponsoring Caitlin Clark. Should You Buy the Stock?
June 08, 2024
One of the most lucrative sports sponsorship opportunities is jersey patches, and one leading pharmaceutical company may have just struck gold.
Via
The Motley Fool
Profiting from the Crowd: 3 Stocks Set to Surge on Retail Investor Enthusiasm
June 08, 2024
You can use the wisdom of crowds and their fear and greed motives to profit from these three stocks to buy with plenty of room to run.
Via
InvestorPlace
SPDR ETF Report For Friday, June 7
June 08, 2024
In this video, Ira Epstein reviews the day's trading in various SPDR-ETF markets for the trading day that ended, Friday, June 7.
Via
Talk Markets
Topics
ETFs
10 Health Care Stocks With Whale Alerts In Today's Session
June 07, 2024
Via
Benzinga
Stocks Choppy As 'Higher for Longer' Fed Rhetoric Weighs
June 07, 2024
Stocks are out of their morning rut, but trading is still choppy to end the week.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Over 10,000 Lawsuits In Novo Nordisk's Ozempic Case Assigned to New Judge
June 07, 2024
Judge Karen Marston takes over the high-profile Ozempic litigation involving over 10,000 lawsuits. Here's the latest.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Wall Street Reacts To Hot Jobs Report: Stocks Swing As Traders Abandon July Rate Cut Hopes
June 07, 2024
May labor market report: strong job gains and wage growth, reduces chances of rate cut. Interest-rate sensitive sectors underperform. Top risers: APD, URI, LLY, HUBB, ADP. Top losers: GEN, SHW, FCX,...
Via
Benzinga
Stock Market Revs To Highs On Nvidia, CrowdStrike, Yields: Weekly Review
June 07, 2024
The Nasdaq and S&P 500 hit record highs, but small caps retreated.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
ETFs Bet High On Weight Loss Drugs, But Industry Observers Question Long-Term Potential
June 07, 2024
New ETFs focusing on weight-loss drugs have launched. However, industry observers caution about their long-term prospects and the concentrated risks associated with these investments.
Via
Benzinga
Topics
ETFs
Ozempic, Wegovy Create Domino Effect As New Products Emerge Across Industries To Capture New Consumer Habits
June 07, 2024
Companies from food and beverage to fitness are adapting to the increased demand for these drugs, hoping to capitalize on shifting consumer habits
Via
Benzinga
Is This Trend a Threat to Eli Lilly's Weight Loss Drug Dominance?
June 07, 2024
The weight loss drug market is growing rapidly.
Via
The Motley Fool
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.